Vanessa
Roldan Schilling
Catedraticos de Universidad Vinculados H.V.Arrixaca
![Foto de Juan Miguel](/img/nophoto.png)
Juan Miguel
Ruiz Nodar
Publicaciones en las que colabora con Juan Miguel Ruiz Nodar (11)
2022
-
Current trends on antithrombotic therapy
REC: CardioClinics
2020
-
Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology
Revista Espanola de Cardiologia, Vol. 73, Núm. 9, pp. 749-757
2018
-
Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU
Revista Espanola de Cardiologia, Vol. 71, Núm. 7, pp. 553-564
2016
-
On the Way to a Better Use of Anticoagulants in Nonvalvular Atrial Fibrillation. Proposed Amendment to the Therapeutic Positioning Report UT/V4/23122013
Revista Espanola de Cardiologia, Vol. 69, Núm. 6, pp. 551-553
2013
-
Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting
Age and Ageing, Vol. 42, Núm. 1, pp. 70-75
2012
-
Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
Circulation: Cardiovascular Interventions, Vol. 5, Núm. 4, pp. 459-466
2011
-
An evaluation of the CHADS2 stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization
Chest, Vol. 139, Núm. 6, pp. 1402-1409
2010
-
The prognostic value of biomarkers after a premature myocardial infarction
International Journal of Cardiology, Vol. 143, Núm. 3, pp. 249-254
2009
-
Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation
European Heart Journal, Vol. 30, Núm. 8, pp. 932-939
-
Premature coronary artery disease in young (age < 45) subjects: Interactions of lipid profile, thrombophilic and haemostatic markers
International Journal of Cardiology, Vol. 136, Núm. 2, pp. 222-225